glp 1 and ct scan Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic? GLP-1 Agonists May Interfere with

The phase 2b SYMMETRY trial, a multicenter, randomized, double-blind, placebo-controlled study, included 181 patients with compensated cirrhosis (Child-Pugh A) due to MASH (78% with histological diagnosis and 22% with cryptogenic cirrhosis attributed to MASH) assigned to receive efruxifermin at doses of 28 or 50 mg, or placebo (1:1:1), for 96 weeks

Effects typically last several hours

Applications AHK-Cu: Commonly used in cosmetics and anti-aging treatments, it is often incorporated into serums, creams, and lotions designed for wrinkle reduction and skin regeneration

These medications help address the hormonal changes that contribute to weight regain, making them a valuable tool in the treatment of weight regain after VSG

A 12-week facial cream study with 71 women documented increased skin density and thickness, reduced laxity, and improved clarity